Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2013
04/03/2013CN103006480A Anti-acne facial cleanser production method
04/03/2013CN103006479A Bubble mud for bathing and preparation method thereof
04/03/2013CN103006460A Skin-caring composition and preparation method and applications thereof
04/03/2013CN103006453A Iodine-containing sterilizing shampoo
04/03/2013CN103005959A Medical pillow
04/03/2013CN103005958A Medical pillow
04/03/2013CN103005954A Medical pillow
04/03/2013CN103005942A Medical pillow
04/03/2013CN102626382B Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection
04/03/2013CN102366579B Preparation method of traditional Chinese medicine lotion for treating clothes lack-type bedsore
04/03/2013CN102366478B Composition for whitening skin and resisting senescence, preparation method and application thereof
04/03/2013CN102357147B Chinese medicine composite tincture capable of diminishing inflammation, relieving pain and preventing viruses and preparation method thereof
04/03/2013CN102349977B External ointment for treating wound pain and preparation method thereof
04/03/2013CN102335376B Compound preparation with stronger antibacterial and itch relieving functions of plant extract
04/03/2013CN102309698B Externally applied drug for treating burns and scalds
04/03/2013CN102302736B Traditional Chinese medicine for treating lipoma disease
04/03/2013CN102302703B Medicament for treating chloasma
04/03/2013CN102293957B Chinese medicinal granules for treating related skin disease such as blood heat yang floating disease and preparation method thereof
04/03/2013CN102283941B Crocodile emu oil scald and burn ointment and preparation method thereof
04/03/2013CN102274473B Compound natural plant hair loss preventing liquid and preparation method and application thereof in shampoo liquid
04/03/2013CN102266425B Micron psoriasis-treating tea and preparation method thereof
04/03/2013CN102258590B Calamine and natural indigo ointment and preparation method thereof
04/03/2013CN102247511B High-efficiency burn treating medicine and preparation method thereof
04/03/2013CN102247442B Traditional Chinese medicine composition and preparation with mosquito repelling and itching relieving efficacies, and preparation method thereof
04/03/2013CN102210829B Multiflower knotweed tuber and mulberry health-care pill
04/03/2013CN102205081B External liquid medicine capable of treating various skin diseases and preparation method thereof
04/03/2013CN102174097B Actinoporin and application thereof
04/03/2013CN102127054B 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite
04/03/2013CN102108090B Dihydroiso-coumarin glucoside compounds and preparation method and application thereof
04/03/2013CN102091097B Washing-free puerpera perineum medical-care gel and preparation method thereof
04/03/2013CN102086195B Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof
04/03/2013CN102047997B Wuyi Mountain rock tea extract, and preparation method and application thereof
04/03/2013CN101999553B Feed additive for controlling livestock sand crack
04/03/2013CN101987844B Method for synthesizing 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-diazepoxide-4-radical)-1-(2H)-phthalizine hydrochloride
04/03/2013CN101897683B Transdermal hormone delivery system: compositions and methods
04/03/2013CN101857594B Tetrahydropyridoindole compounds, and preparation method and application thereof
04/03/2013CN101829161B Organic selenium and taurine compound preparation as well as preparation method and application thereof in radiation resistance
04/03/2013CN101801414B Oral and skin compositions
04/03/2013CN101744885B Application of cassia oil in preparation of Alpha 5-reductase inhibitor medicaments
04/03/2013CN101721594B Chinese medicinal ointment with antibacterial and antipruritic effects and preparation method thereof
04/03/2013CN101514177B Method for extracting lutein from marigold particles
04/03/2013CN101189017B Method of using oxidative reductive potential water solution in dental applications
04/02/2013US8410266 2,4-pyrimidinediamine compounds and their uses
04/02/2013US8410174 Method for treating arthritis
04/02/2013US8410053 Methods for treating autoimmune disorders, and reagents related thereto
04/02/2013US8409612 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
04/02/2013US8409610 Wound care device
04/02/2013US8409595 Method for decreasing sebum production
04/02/2013CA2702032C Skin property-improving therapeutic agent comprising a morphinan derivative or any of its pharmacologically permissible acid addition salts as an active ingredient
04/02/2013CA2632067C Method for improving absorbability of epigallocatechin gallate, foods, drinks and food/drink materials using the same and method for producing the same
04/02/2013CA2588410C 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses
04/02/2013CA2582974C Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods
04/02/2013CA2550843C Novel phenylalanine derivatives
04/02/2013CA2532799C Human antibody molecules for il-13
04/02/2013CA2525049C Insoluble globin injectable implant
04/02/2013CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3
04/02/2013CA2470920C Liposomal delivery of vitamin e based compounds
04/02/2013CA2455756C Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
03/2013
03/28/2013WO2013044251A1 Anti-stretch mark skin cream and method for making and using thereof
03/28/2013WO2013044098A1 Compositions and methods for treating conditions of compromised skin barrier function
03/28/2013WO2013042989A1 Percutaneously absorbable preparation containing fentanyl and a homologue thereof
03/28/2013WO2013042782A1 Condensed heterocyclic compound
03/28/2013WO2013041859A1 Cannabinoid-2-receptor agonists
03/28/2013WO2013041719A1 Tripeptide kdpt for antiapoptotic treatment
03/28/2013WO2013041646A1 Formulation and treatment for acne
03/28/2013WO2013041537A1 Heterocyclocarbonylaminothiazoles, cosmetic or dermatological preparations containing said heterocyclocarbonylaminothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin
03/28/2013WO2013041535A1 Aromatic amidothiazoles, cosmetic or dermatological preparations containing said aromatic amidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin
03/28/2013WO2013041526A1 Alkylamidothiazoles, cosmetic or dermatological preparations containing said alkylamidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin
03/28/2013WO2013041247A1 Yersinia outer protein m (yopm) in the treatment of psoriasis induced by imiquimod
03/28/2013WO2013041246A1 Yersinia outer protein m (yopm) in the treatment of psoriasis
03/28/2013WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
03/28/2013WO2013040649A1 Therapeutics using adipose cells and cell secretions
03/28/2013WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
03/28/2013WO2013003465A9 Methods and compositions for treating skin
03/28/2013WO2012158018A3 Compositions comprising extracts or materials derived from palm oil vegetation liguor for inhibition of vision loss due to angiogenesis and method of preparation thereof
03/28/2013US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells"
03/28/2013US20130079387 Antisense oligonucleotide modulation of raf gene expression
03/28/2013US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079337 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
03/28/2013US20130079332 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
03/28/2013US20130079317 Methods for treatment of diseases
03/28/2013US20130079312 Method of Treating Hair Loss Due to Systemic Chemotherapy
03/28/2013US20130079287 Caffeoylalphaneoendorphin peptide derivative and use thereof as anti-itching and anti-atopic agents
03/28/2013US20130078237 Cd27l antigen binding proteins
03/28/2013CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
03/28/2013CA2848943A1 Compositions and methods for treating conditions of compromised skin barrier function
03/28/2013CA2845478A1 Yersinia outer protein m (yopm) in the treatment of psoriasis
03/28/2013CA2845183A1 Tripeptide kdpt for antiapoptotic treatment
03/27/2013EP2572720A1 Formulation and treatment for acne
03/27/2013EP2571532A2 Il-1 binding proteins
03/27/2013EP2571507A1 Formulations and methods of treatment of skin conditions
03/27/2013CN1899257B Plant based formulations for improving skin moisture, texture, and appearance
03/27/2013CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same
03/27/2013CN103002907A Eczema treatment
03/27/2013CN103002903A Keloid treatment
03/27/2013CN102995492A Manufacture method of mosquito repelling tissue
03/27/2013CN102994336A Medicinal liquor for beautifying
03/27/2013CN102993320A Isolates of radix hedysari polysaccharide 3 and application thereof
03/27/2013CN102993306A High affinity, anti-human IgE antibodies